IFN-α protein showed a non-significant trend to be at higher concentrations in HCV patients with cirrhosis compared with those without cirrhosis, showing only a slow and partial decrease on- and post-therapy (Supplementary Figure 8). This evidence concerns the gene IFNA2 and Cirrhosis.